Plans to initiate Phase 2 clinical trial in Adrenocortical Carcinoma in early 2026 through unique partnership between Cytovation, Cancer Research UK and the Norwegian Cancer Society
You might also be interested in reading BitMine Immersion Surges 40% After Revealing $500M ETH Treasury.